| Literature DB >> 34725407 |
Shun Ishibashi1, Kenichi Sakakura2, Satoshi Asada1, Yousuke Taniguchi1, Hiroyuki Jinnouchi1, Takunori Tsukui1, Kei Yamamoto1, Masaru Seguchi1, Hiroshi Wada1, Hideo Fujita1.
Abstract
In percutaneous coronary intervention (PCI) to the culprit lesion of acute myocardial infarction (AMI), unsuccessful guidewire crossing causes immediate poor outcomes. It is important to determine the factors associated with unsuccessful guidewire crossing in AMI lesions. The purpose of this study was to find factors associated with difficulty in crossing the culprit lesion of AMI. We defined the difficult group when the guidewire used to cross the culprit lesion was a polymer jacket type guidewire or a stiff guidewire. We included 937 patients, and divided those into the non-difficult group (n = 876) and the difficult group (n = 61). Proximal reference diameter was significantly smaller in the difficult group than in the non-difficult group (p < 0.001), and degree of calcification was severer in the difficult group than in the non-difficult group (p < 0.001). In the multivariate stepwise logistic regression analysis, proximal reference diameter [odds ratio (OR) 0.313, 95% confidence interval (CI) 0.185-0.529, p < 0.001)], previous PCI (OR 3.065, 95% CI 1.612-5.830, p = 0.001), moderate-severe calcification (OR 4.322, 95% CI 2.354-7.935, p < 0.001), blunt type obstruction (OR 12.646, 95% CI 6.805-23.503, p < 0.001), and the presence of collateral to the culprit lesion (OR 2.110, 95% CI 1.145-3.888, p = 0.017) were significantly associated with difficulty in crossing the culprit lesion. In conclusion, previous PCI, calcification, blunt type obstruction, and the presence of collateral were associated with difficulty in crossing the culprit lesion, whereas proximal reference diameter was inversely associated with difficulty. Our study provides a reference to recognize the difficulty in crossing the culprit lesions of AMI for PCI operators, especially junior operators.Entities:
Mesh:
Year: 2021 PMID: 34725407 PMCID: PMC8560938 DOI: 10.1038/s41598-021-00832-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The study flow-chart. Abbreviations: AMI = acute myocardial infarction.
Comparison of patient’s characteristics between the non-difficult group and the difficult group.
| All n = 937 | Non-difficult group n = 876 | Difficult group n = 61 | ||
|---|---|---|---|---|
| Age, years | 70.2 ± 12.5 | 70.0 ± 12.6 | 73.8 ± 9.7 | 0.027 |
| Male, n (%) | 711 (75.9) | 669 (76.4) | 42 (68.9) | 0.185 |
| Height (cm) | 161.7 ± 10.2 (n = 934) | 161.9 ± 10.2 (n = 873) | 158.9 ± 9.9 | 0.021 |
| Body weight (kg) | 63.1 ± 13.6 (n = 934) | 63.3 ± 13.6 (n = 873) | 60.5 ± 13.2 | 0.080 |
| Systolic blood pressure at admission (mmHg) | 140.3 ± 32.8 (n = 932) | 140.0 ± 32.6 (n = 871) | 144.7 ± 35.3 | 0.283 |
| Diastolic blood pressure at admission (mmHg) | 80.5 ± 20.5 (n = 931) | 80.4 ± 20.3 (n = 870) | 82.0 ± 22.6 | 0.566 |
| Heart rate at admission (beat per minute) | 82.0 ± 22.3 (n = 933) | 81.4 ± 21.5 (n = 872) | 89.3 ± 31.0 | 0.123 |
| Hypertension, n (%) | 762/936 (81.4) | 708/875 (80.9) | 54 (88.5) | 0.140 |
| Diabetes mellitus, n (%) | 417/931 (44.8) | 384/871 (44.1) | 33/60 (55.0) | 0.100 |
| Dyslipidemia, n (%) | 583/932 (62.6) | 539/871 (61.9) | 44 (72.1) | 0.110 |
| Hemodialysis, n (%) | 89 (9.5) | 79 (9.0) | 10 (16.4) | 0.057 |
| History of previous PCI, n (%) | 209 (22.3) | 187 (21.3) | 22 (36.1) | 0.008 |
| History of previous CABG, n (%) | 38 (4.1) | 34 (3.9) | 4 (6.6) | 0.306 |
| History of previous MI, n (%) | 148 (15.8) | 140 (16.0) | 8 (13.1) | 0.553 |
| Current smoker, n (%) | 291/920 (31.6) | 277/860 (32.2) | 14/60 (23.3) | 0.153 |
| Aspirin, n (%) | 304/930 (32.7) | 273/870 (31.4) | 31/60 (51.7) | 0.001 |
| Thienopyridine, n (%) | 181/930 (19.5) | 161//870 (18.5) | 20/60 (33.3) | 0.005 |
| Beta-blocker, n (%) | 222/911 (24.4) | 203/852 (23.8) | 19/59 (32.2) | 0.147 |
| ACE-inhibitor, ARB, n (%) | 370/912 (40.6) | 344/853 (40.3) | 26/59 (44.1) | 0.572 |
| Calcium channel blocker, n (%) | 347/910 (38.1) | 325/851 (38.2) | 22/59 (37.3) | 0.890 |
| Statin, n (%) | 327/917 (35.7) | 299/858 (34.8) | 28/59 (47.5) | 0.050 |
| Diuretic, n (%) | 124/915 (13.6) | 112/856 (13.1) | 12/59 (20.3) | 0.115 |
| Hypoglycemic agents, n (%) | 242/920 (26.3) | 217/861 (25.2) | 25/59 (42.4) | 0.004 |
| Insulin, n (%) | 63/922 (6.8) | 57/863 (6.6) | 6/59 (10.2) | 0.294 |
| Serum creatinine (mg/dl) | 1.66 ± 2.31 | 1.61 ± 2.24 | 2.30 ± 3.16 | 0.419 |
| Estimated GFR (ml/min/1.73m2) | 60.9 ± 31.8 | 61.0 ± 29.6 | 60.3 ± 54.7 | 0.242 |
| Hemoglobin (g/dl) | 13.2 ± 2.14 | 13.2 ± 2.09 | 12.5 ± 2.61 | 0.016 |
| BNP (pg/ml) | 420.3 ± 686.3 (n = 891) | 394.4 ± 656.1 (n = 831) | 778.3 ± 953.5 (n = 60) | < 0.001 |
| 0.003 | ||||
| 1 or 2 | 736 (78.5) | 697 (79.6) | 39 (63.9) | |
| 3 | 99 (10.6) | 85 (9.7) | 14 (23.0) | |
| 4 | 102 (10.9) | 94 (10.7) | 8 (13.1) | |
| Cardiac arrest at prehospital or ER, n (%) | 55 (5.9) | 48 (5.5) | 7 (11.5) | 0.054 |
| Shock vital at prehospital or ER, n (%) | 117 (12.5) | 109 (12.4) | 8 (13.1) | 0.878 |
| Admission within 24 h of onset | 796/932 (85.4) | 751/871 (86.2) | 45 (73.8) | 0.008 |
| STEMI (vs NSTEMI) | 563 (60.1) | 533 (60.8) | 30 (49.2) | 0.072 |
| 0.456 | ||||
| Left main – left anterior descending artery, n (%) | 477 (50.9) | 443 (50.6) | 34 (55.7) | |
| Right coronary artery, n (%) | 311 (33.2) | 296 (33.8) | 15 (24.6) | |
| Left circumflex, n (%) | 141 (15.0) | 130 (14.8) | 11 (18.0) | |
| Graft, n (%) | 8 (0.9) | 7 (0.8) | 1 (1.6) | |
| 0.031 | ||||
| 1 vessel disease, n (%) | 403 (43.0) | 382 (43.6) | 21 (34.4) | |
| 2 vessel disease, n (%) | 311 (33.2) | 294 (33.6) | 17 (27.9) | |
| 3 vessel disease, n (%) | 223 (23.8) | 200 (22.8) | 23 (37.7) | |
| Left main trunk lesion, n (%) | 101 (10.8) | 95 (10.8) | 6 (9.8) | 0.806 |
| Left main trunk bifurcation lesion, n (%) | 53 (5.7) | 50 (5.7) | 3 (4.9) | 0.796 |
| Ostia lesion, n (%) | 77 (8.2) | 69 (7.9) | 8 (13.1) | 0.150 |
| Bifurcation lesion, n (%) | 217 (23.2) | 207 (23.6) | 10 (16.4) | 0.195 |
| 0.003 | ||||
| 0 | 350 (37.4) | 319 (36.4) | 31 (50.8) | |
| 1 | 88 (9.4) | 79 (9.0) | 9 (14.8) | |
| 2 | 160 (17.1) | 148 (16.9) | 12 (19.7) | |
| 3 | 339 (36.2) | 330 (37.7) | 9 (14.8) | |
| 0.002 | ||||
| 0 | 0 | 0 | 0 | |
| 1 | 479 (51.1) | 458 (52.3) | 21 (34.4) | |
| 2 | 34 (3.6) | 34 (3.9) | 0 | |
| 3 | 50 (5.3) | 49 (5.6) | 1 (1.6) | |
| 4 | 20 (2.1) | 18 (2.1) | 2 (3.3) | |
| 5 | 354 (37.8) | 317 (36.2) | 37 (60.7) | |
| Lesion length (mm) | 16.1 ± 10.2 | 16.0 ± 10.1 | 18.0 ± 11.7 | 0.279 |
| Reference diameter (mm) | 2.57 ± 0.75 | 2.59 ± 0.75 | 2.18 ± 0.65 | < 0.001 |
| Proximal reference diameter (mm) | 2.72 ± 0.66 | 2.79 ± 0.65 | 2.43 ± 0.65 | < 0.001 |
| Tortuosity | 0.481 | |||
| Mild tortuosity, n (%) | 815 (87.0) | 765 (87.3) | 50 (82.0) | |
| Moderate tortuosity, n (%) | 87 (9.3) | 79 (9.0) | 8 (13.1) | |
| Excessive tortuosity, n (%) | 35 (3.7) | 32 (3.7) | 3 (4.9) | |
| 0.088 | ||||
| Concentric, n (%) | 871 (93.0) | 811 (92.6) | 60 (98.4) | |
| Eccentric, n (%) | 66 (7.0) | 65 (7.4) | 1 (1.6) | |
| Calcification | < 0.001 | |||
| None-mild, n (%) | 709 (75.7) | 680 (77.6) | 29 (47.5) | |
| Moderate, n (%) | 132 (14.1) | 113 (12.9) | 19 (31.1) | |
| Severe, n (%) | 96 (10.2) | 83 (9.5) | 13 (21.3) | |
| < 0.001 | ||||
| Blunt | 171 (18.2) | 131 (15.0) | 40 (65.6) | |
| Tapered | 766 (81.7) | 745 (85.0) | 21 (34.4) | |
| In-stent lesion | 80 (8.5) | 69 (7.9) | 11 (18.0) | 0.006 |
| 0.001 | ||||
| 0 | 701 (74.8) | 668 (76.3) | 33 (54.1) | |
| 1 | 165 (17.6) | 148 (16.9) | 17 (27.9) | |
| 2 | 66 (7.0) | 56 (6.4) | 10 (16.4) | |
| 3 | 5 (0.5) | 4 (0.5) | 1 (1.6) | |
| Occurrence of slow flow in PCI, n (%) | 63 (6.7) | 61 (7.0) | 2 (3.3) | 0.267 |
| 0.070 | ||||
| Trans-radial coronary intervention, n (%) | 565 (60.3) | 536 (61.2) | 29 (47.5) | |
| Trans-brachial coronary intervention, n (%) | 32 (3.4) | 28 (3.2) | 4 (6.6) | |
| Trans-femoral coronary intervention, n (%) | 340 (36.3) | 312 (35.6) | 28 (45.9) | |
| 0.009 | ||||
| Plain old balloon angioplasty, n (%) | 54 (5.8) | 46 (5.3) | 8 (13.1) | |
| Aspiration only, n (%) | 6 (0.6) | 6 (0.7) | 0 | |
| Drug coating balloon angioplasty, n (%) | 42 (4.5) | 37 (4.2) | 5 (8.2) | |
| Bare metal stent, n (%) | 23 (2.5) | 22 (2.5) | 1 (1.6) | |
| Drug eluting stent, n (%) | 803 (85.7) | 758 (86.5) | 45 (73.8) | |
| POBA and aspiration, n (%) | 6 (0.6) | 4 (0.5) | 2 (3.3) | |
| Other, n (%) | 3 (0.3) | 3 (0.3) | 0 | |
| < 0.001 | ||||
| 6 | 584 (62.4) | 563 (64.3) | 21 (34.4) | |
| 7 | 343 (36.6) | 307 (35.0) | 36 (59.0) | |
| 8 | 10 (1.1) | 6 (0.7) | 4 (6.6) | |
| < 0.001 | ||||
| 1 | 868 (92.6) | 822 (93.8) | 46 (75.4) | |
| 2 | 61 (6.5) | 49 (5.6) | 12 (19.7) | |
| ≥ 3 | 8 (0.9) | 5 (0.6) | 3 (4.9) | |
| < 0.001 | ||||
| 1 | 506 (54.0) | 506 (57.8) | 0 | |
| 2 | 315 (33.6) | 287 (32.8) | 28 (45.9) | |
| ≥ 3 | 116 (12.4) | 83 (9.5) | 33 (54.1) | |
| 0.002 | ||||
| 0 | 121 (12.9) | 105 (12.0) | 16 (26.2) | |
| 1 | 710 (75.8) | 676 (77.2) | 34 (55.7) | |
| 2 | 98 (10.5) | 88 (10.0) | 10 (16.4) | |
| ≥ 3 | 8 (0.9) | 7 (0.8) | 1 (1.6) | |
| < 0.001 | ||||
| 0 | 29 (3.1) | 29 (3.3) | 0 | |
| 1 | 409 (43.6) | 392 (44.7) | 17 (27.9) | |
| 2 | 350 (37.4) | 328 (37.4) | 22 (36.1) | |
| ≥ 3 | 149 (15.9) | 127 (14.5) | 22 (36.1) | |
| Use of guide-extension-catheter, n (%) | 94 (10.0) | 81 (9.2) | 13 (21.3) | 0.002 |
| Use of microcatheter, n (%) | 279 (29.8) | 222 (25.3) | 57 (93.4) | < 0.001 |
| Use of aspiration catheter, n (%) | 152 (16.2) | 146 (16.7) | 6 (9.8) | 0.162 |
| Use of rotational coronary atherectomy, n (%) | 42 (4.5) | 37 (4.2) | 5 (8.2) | 0.147 |
| IVUS guide, n (%) | 907 (96.8) | 848 (96.8) | 59 (96.7) | 0.972 |
| OCT/OFDI guide, n (%) | 19 (2.0) | 19 (2.2) | 0 | 0.245 |
| Temporary pacemaker, n (%) | 67 (7.2) | 63 (7.2) | 4 (6.6) | 0.852 |
| Intra-aortic balloon pumping support, n (%) | 97 (10.4) | 90 (10.3) | 7 (11.5) | 0.766 |
| V-A ECMO, n (%) | 28 (3.0) | 26 (3.0) | 2 (3.3) | 0.890 |
| Amount of contrast media (ml) | 126.6 ± 48.7 | 125.5 ± 47.8 | 142.8 ± 58.1 | 0.010 |
| Fluoroscopy time (minutes) | 24.7 ± 14.1 | 23.4 ± 12.5 | 43.0 ± 21.9 | < 0.001 |
Data are expressed as the mean ± SD or number (percentage). A Student’s t test was used for normally distributed continuous variables, a Mann–Whitney U test was used for abnormally distributed continuous variables, and a chi-square test was used for categorical variables.
PCI indicates percutaneous coronary intervention, CABG coronary artery bypass grafting, MI myocardial infarction, ACE Angiotensin converting enzyme, ARB Angiotensin II receptor blocker, GFR glemerular filtration rate, BNP brain natriuretic peptide, ER emergency room, TIMI Thrombolysis in myocardial infarction, IVUS intravascular ultrasound, OCT/OFDI optical coherence tomography/optical frequency domain imaging, V-A ECMO veno-arterial extra-corporeal membranous oxygenation.
Univariate logistic regression analysis to find association with the difficulty in crossing the culprit lesion.
| Independent variables | Odds ratio | 95% confidence interval | |
|---|---|---|---|
| Age | 1.027 | 1.004–1.051 | 0.020 |
| male sex | 0.684 | 0.389–1.202 | 0.187 |
| Height (per 10 cm incremental) | 0.812 | 0.660–0.999 | 0.049 |
| Body weight (per 10 kg incremental) | 0.851 | 0.698–1.037 | 0.110 |
| Systolic blood pressure (mmHg) (per 10 mmHg incremental) | 1.049 | 0.969–1.135 | 0.236 |
| Diastolic blood pressure (mmHg) (per 10 mmHg incremental) | 1.037 | 0.915–1.174 | 0.571 |
| Heart rate (beat per minute) (per 10 bpm incremental) | 1.143 | 1.028–1.271 | 0.014 |
| Hypertension | 1.820 | 0.813–4.071 | 0.145 |
| Diabetes mellitus | 1.550 | 0.916–2.623 | 0.102 |
| Dyslipidemia | 1.594 | 0.896–2.836 | 0.113 |
| Hemodialysis | 1.978 | 0.967–4.049 | 0.062 |
| History of previous MI | 0.794 | 0.369–1.705 | 0.554 |
| History of previous PCI | 2.078 | 1.203–3.592 | 0.009 |
| History of previous CABG | 1.738 | 0.596–5.068 | 0.311 |
| Current smoker | 0.641 | 0.346–1.185 | 0.156 |
| Aspirin | 2.338 | 1.381–3.956 | 0.002 |
| Thienopyridine | 2.202 | 1.253–3.868 | 0.006 |
| Beta-blocker | 1.519 | 0.860–2.681 | 0.150 |
| ACE-inhibitor, ARB | 1.166 | 0.685–1.984 | 0.572 |
| Calcium channel blocker | 0.962 | 0.558–1.660 | 0.890 |
| Statin | 1.689 | 0.994–2.869 | 0.053 |
| Diuretic | 1.696 | 0.873–3.296 | 0.119 |
| Hypoglycemic agents | 2.182 | 1.273–3.740 | 0.005 |
| Insulin | 1.601 | 0.660–3.882 | 0.298 |
| Serum creatinine (mg/dl) | 1.102 | 1.011–1.200 | 0.027 |
| Estimated GFR (ml/min/1.73m2) | 0.999 | 0.991–1.008 | 0.871 |
| Hemoglobin (g/dl) | 0.865 | 0.769–0.974 | 0.016 |
| BNP (pg/ml) (per 100 pg/ml incremental) | 1.055 | 1.027–1.083 | < 0.001 |
| 4 versus 1–3 | 1.256 | 0.579–2.722 | 0.564 |
| Cardiac arrest at prehospital or ER | 2.236 | 0.966–5.177 | 0.060 |
| Shock vital at prehospital or ER | 1.062 | 0.492–2.294 | 0.878 |
| Admission within 24 h of onset | 0.449 | 0.246–0.821 | 0.009 |
| STEMI (vs. NSTEMI) | 0.623 | 0.370–1.047 | 0.074 |
| Left main—left anterior descending artery versus others | 1.231 | 0.730–2.075 | 0.436 |
| 3 vessel disease versus 1 or 2 vessel disease | 2.046 | 1.191–3.515 | 0.010 |
| Left main trunk lesion | 0.897 | 0.376–2.139 | 0.806 |
| Left main trunk bifurcation lesion | 0.854 | 0.259–2.823 | 0.796 |
| Ostia lesion | 1.765 | 0.807–3.863 | 0.155 |
| Bifurcation lesion | 0.634 | 0.316–1.270 | 0.199 |
| 3 versus 0–2 | 0.286 | 0.139–0.589 | 0.001 |
| 4–5 versus 0–3 | 2.863 | 1.668–4.913 | < 0.001 |
| Lesion length (mm) (per 10 mm incremental) | 1.189 | 0.968–1.461 | 0.099 |
| Reference diameter (mm) | 0.387 | 0.252–0.595 | < 0.001 |
| Proximal reference diameter (mm) | 0.392 | 0.249–0.618 | < 0.001 |
| Excessive tortuosity versus mild-moderate tortuosity | 1.364 | 0.406–4.589 | 0.616 |
| Eccentric versus concentric | 0.208 | 0.028–1.525 | 0.122 |
| Moderate-severe versus none-mild | 3.828 | 2.260–6.485 | < 0.001 |
| Blunt versus tapered | 10.832 | 6.188–18.961 | < 0.001 |
| In-stent lesion | 2.573 | 1.281–5.168 | 0.008 |
| 1–3 versus 0 | 2.777 | 1.639–4.706 | < 0.001 |
| Occurrence of slow flow in PCI | 0.453 | 0.108–1.898 | 0.279 |
| Trans radial coronary intervention versus TFI or TBI | 0.575 | 0.342–0.967 | 0.037 |
| Drug eluting stent versus others | 0.438 | 0.240–0.800 | 0.007 |
| ≥ 7 versus 6Fr | 3.426 | 1.985–5.914 | < 0.001 |
| ≥ 2 versus 1 | 4.964 | 2.606–9.456 | < 0.001 |
| ≥ 2 versus 0–1 | 1.787 | 0.900–3.551 | 0.097 |
| ≥ 3 versus 0–2 | 3.327 | 1.909–5.798 | < 0.001 |
| Use of extension guide catheter | 2.958 | 1.382–5.113 | 0.003 |
| Use of micro catheter | 41.98 | 15.060–117.019 | < 0.001 |
| Use of aspiration catheter | 0.545 | 0.231–1.291 | 0.168 |
| Use of rotational coronary atherectomy | 2.025 | 0.766–5.353 | 0.155 |
| Temporary pacemaker | 0.906 | 0.318–2.577 | 0.853 |
| Intra-aortic balloon pumping support | 1.132 | 0.500–2.563 | 0.766 |
| V-A ECMO | 1.108 | 0.257–4.783 | 0.890 |
Multivariate logistic regression analysis model to find association with the difficulty in crossing the culprit lesion.
| Dependent variable : the difficulty in crossing the culprit lesion | |||
|---|---|---|---|
| Independent variables | Odds ratio | 95% confidence interval | |
| Proximal reference diameter | 0.313 | 0.185–0.529 | < 0.001 |
| Previous PCI | 3.065 | 1.612–5.830 | 0.001 |
| Moderate-severe calcification (vs. none-mild) | 4.322 | 2.354–7.935 | < 0.001 |
| Blunt type of obstruction site (vs. tapered) | 12.646 | 6.805–23.503 | < 0.001 |
| The presence of collateral to the culprit lesion (Rentrop grade1–3) | 2.110 | 1.145–3.888 | 0.017 |
The stepwise model includes the following variables: age, proximal reference, previous PCI, number of diseased vessels, initial TIMI flow grade of culprit, calcification, type of obstruction site, the presence of collateral to the culprit lesion, In-stent lesion, TIMI thrombus grade.